Boryung to present clinical results of new antihypertensive agent

Published: 2010-09-28 06:58:00

Updated: 2010-09-28 06:58:00

Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, said it will announce the results of safety and efficacy on a new antihypertensive drug in the 23rd Scientific Meeting of International Society of Hypertension (ISH), to be held from September 26 to 30, 2010 in Vancouver...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK